Ultragenyx Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-579.83	-569.18	-606.64	-707.42	-454.03	-186.57
Depreciation & Amortization	35.29	35.54	26.01	18.22	13.24	12.26
Asset Writedown & Restructuring Costs	-	-	-	75.03	-	-
Loss (Gain) From Sale of Investments	-5.18	-11.51	-13.24	22	48.67	-169.56
Stock-Based Compensation	155.88	158.03	135.23	130.38	104.95	85.74
Other Operating Activities	-51	-40.99	-1.06	21.09	11.71	21.24
Change in Accounts Receivable	-17.81	-33.6	-22.78	-12.07	-5.43	9.84
Change in Inventory	-8.61	-11.21	-6.93	-9.7	-3.12	-1.35
Change in Accounts Payable	33.37	46.99	0.9	79.85	32.31	26.85
Change in Unearned Revenue	-	-	-	-	-57.49	66.57
Change in Other Net Operating Assets	-7.8	11.73	15.33	3.8	-29.51	2.75
Operating Cash Flow	-445.67	-414.19	-474.81	-380.47	-338.7	-132.22
Capital Expenditures	-5.72	-7.49	-44.27	-116.12	-73.09	-43.91
Cash Acquisitions	-	-	-	-75.03	-	-
Sale (Purchase) of Intangibles	-15	-12.5	-2.5	-30	-	-
Investment in Securities	433.1	4.66	219.82	-69.66	-121.34	-129.66
Other Investing Activities	-1.4	-2.44	-5.05	-0.84	-0.94	-5.56
Investing Cash Flow	410.98	-17.77	168	-291.65	-195.37	-179.12
Issuance of Common Stock	86.99	392.24	388.17	10.81	119.04	600.51
Other Financing Activities	-	7	-0.03	490.4	-0.49	-0.24
Financing Cash Flow	86.99	399.24	388.14	501.21	118.55	600.27
Foreign Exchange Rate Adjustments	2.18	-2.53	0.46	-1.08	-1.19	1.12
Net Cash Flow	54.49	-35.24	81.8	-171.98	-416.71	290.05
Free Cash Flow	-451.39	-421.68	-519.07	-496.59	-411.79	-176.13
Free Cash Flow Margin	-71.58%	-75.27%	-119.53%	-136.68%	-117.18%	-64.98%
Free Cash Flow Per Share	-4.63	-4.66	-7.06	-7.10	-6.07	-2.90
Levered Free Cash Flow	-195.18	-207.49	-312.21	-370.58	-244.82	-86.45
Unlevered Free Cash Flow	-158.89	-168.09	-270.96	-343.7	-226.43	-65.65
Change in Working Capital	-0.84	13.92	-15.1	60.24	-63.24	104.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.